Nebilet (Chronic Heart Failure)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Upcoming Related Reports 8
3 Disease Overview 10
3.1 Etiology and Pathophysiology 10
3.1.1 Etiology 10
3.1.2 Pathophysiology 12
3.2 Prognosis 16
3.3 Quality of Life 16
3.4 Symptoms 17
4 Disease Management 19
4.1 Treatment Overview 20
4.1.1 Pharmacological Treatments 22
4.1.2 Mechanical Devices 28
5 Competitive Assessment 29
5.1 Overview 29
5.2 Strategic Competitor Assessment 29
6 Nebilet (Nebivolol) 32
6.1 Overview 32
6.2 Efficacy 33
6.3 Safety 34
6.4 SWOT Analysis 34
6.5 Forecast 35
7 Appendix 36
7.1 Bibliography 36
7.2 Abbreviations 38
7.3 Methodology 39
7.4 Forecasting Methodology 39
7.4.1 NYHA Class Segmentation of Total Prevalent CHF Population 39
7.4.2 Diagnosed CHF Population 40
7.4.3 Drug-Treated CHF Population 41
7.4.4 Patient Population Breakdown: HF-REF versus HF-PEF 41
7.4.5 Treatment of HF-REF versus HF-PEF 41
7.4.6 General Pricing Assumptions 42
7.4.7 Drugs Assumptions 43
7.4.8 Generic Erosion 43
7.5 Physicians and Specialists Included in this Study 44
7.6 Survey of Prescribing Physicians 45
7.7 About the Authors 46
7.7.1 Author 46
7.7.2 Global Head of Healthcare 46
7.8 About GlobalData 47
7.9 Disclaimer 47